Reasonable CELZ PPS estimations are easy to calculate.
Everything in chemistry, biology, life in general and finance wants to find an equilibrium. I posit that CELZ has settled out at an equilibrium of ~ $0.05 PPS given all current data publicly known and the reality check of real revenue earned by a real doctor (Mssr. Gershman) in Q1.
The variations of price at this point in time are merely the tug-of-war that occurs by us all whilst we wait for more publicly known data points (i.e. revenue indicators).
So...if we can reasonably assume that CELZ is resting at a nickel per share a month after soaking in the FACT of Q1 revenues of $9,600 then the following would be a solid gauge of PPS once we learn Q2's revenues by way of very simple math (i.e. $0.05 over $9,600 = x over "estimated revenue"):
Projected Revenue / Share Price
$50,000 / $0.2604
$100,000 / $0.5208
$150,000 / $0.7813
$200,000+ / $1.0416+
There will be major fluctuations all along the way BUT, if the world of finance has any indicator that holds up RELIABLY over time, it's that real revenue is the best determination for discounted projections which result in actual PPS. CELZ is a beauty because real revenue is happening NOW and we're about to get another dose of it real soon. If one wants to wager about PPS, the game should be focused on what level of revenue we'll see from Q2 because that should provide a fairly comfortable expectation of PPS barring a full blown feature on 60 Minutes. If that happens, Katy bar the door! (in the best of intents)
So, do you want to play a game? Who thinks revenue will top a meager 50K in Q2? ....put me down for one fifty or more...
GLTA and STAY LONG N STRONG --- Especially if the snakes come out to play (we know who you are) while we wait for revenue reports.
-- Narrow is the way and few are those who find it. --
